Related Experiment Video
Updated: Jul 8, 2026

Protocol for Studying Extinction of Conditioned Fear in Naturally Cycling Female Rats
Published on: February 23, 2015
Methodologic ramifications of paying attention to sex and gender differences in clinical research
Martin H Prins1, Kim M Smits, Luc J Smits
1Department of Epidemiology, University of Maastricht, Maastricht, The Netherlands. mh.prins@epid.unimaas.nl
Background:
Methodologic standards for studies on sex and gender differences should be developed to improve reporting of studies and facilitate their inclusion in systematic reviews. The essence of these studies lies within the concept of effect modification.
Objective:
This article reviews important methodologic issues in the design and reporting of pharmacogenetic studies.
Results:
Differences in effect based on sex or gender should preferably be expressed in absolute terms (risk differences) to facilitate clinical decisions on treatment. Information on the distribution of potential effect modifiers or prognostic factors should be available to prevent a biased comparison of differences in effect between genotypes. Other considerations included the possibility of selective nonavailability of biomaterial and the choice of a statistical model to study effect modification.
Conclusion:
To ensure high study quality, additional methodologic issues should be taken into account when designing and reporting studies on sex and gender differences.
Related Concept Videos
Criticisms of the Evolutionary Perspective
Evolutionary psychology provides one explanation for these findings, suggesting...
Bias in Epidemiological Studies
Socioemotional Experience and Gender Development
Case Studies
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Ethics in Research
